Approval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015 along with limited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharma East India Hospitals has reported its Q3 FY26 standalone results. Revenue from operations rose to Rs. 960.88 lakhs, up about 17.9% from Rs. 815.07 lakhs in Q3 FY25. For the nine-month period, revenue grew to Rs. 2,846.70 lakhs versus Rs. 2,388.81 lakhs, a growth of roughly 19.2%. However, profit after tax for the quarter fell sharply to Rs. 17.77 lakhs from Rs. 28.77 lakhs, a decline of about 38%. Nine-month PAT was Rs. 81.35 lakhs versus Rs. 87.74 lakhs, down around 7.3%. Total expenses grew faster than revenue (Q3 expenses rose ~20.6% vs revenue up ~17.9%), driven mainly by higher cost of materials and purchase of stock. EPS for Q3 stood at Rs. 0.54 versus Rs. 0.88 in the year-ago quarter. The auditor (Gopal Sharma & Co.) issued an unmodified limited review report with no qualifications.
Topline growth is healthy but profitability is under clear pressure, with Q3 PAT falling sharply despite revenue gains. Shareholders should watch whether the company can control costs and restore margins in the coming quarters, as the current trend of expenses outpacing revenue growth could weigh on stock sentiment.